Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(S)-(+)-amphetamine
Dextroamphetamine adipate
(αS)-α-methylbenzeneethanamine
(+)-α-methylphenethylamine
d-amphetamine
Dexamphetamine
Dexamfetamine
(S)-(+)-β-phenylisopropylamine
(+)-amphetamine
Dextroamphetamine sulfate
(S)-α-methylbenzeneethanamine
Dexamfetaminum
(S)-amphetamine
(S)-1-phenyl-2-aminopropane
(+)-(S)-amphetamine
Dextroamphetamine saccharate
Desamfetamina
(+)-α-methylphenylethylamine
Dextroamphetamine
Dexanfetamina
(S)-1-phenyl-2-propylamine
Dexamfetamina
Brand Names
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Suflate
Dexedrine Spansule
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
